Page 5 - Trial Data News Today

Clinicians continue their discussion of three new agents approved for the treatment of major depressive disorder (MDD).

Clinicians wrap up their discussion of three new agents approved for the treatment of major depressive disorder (MDD).

Experts shed light on the challenges of seborrheic dermatitis treatment, emphasizing the historical lack of treatment options and importance of patient education.

Learn about the type of bond he receives. >> luke, i want to turn back to jack smiths case. these new developments now, essentially, a defendant changing their testimony. what does this tell you, tell us, frankly, about how jack smith is building this case as we barreled towards some trial data sometime undetermined? >> i think a couple of things. one, i think it shows jack smith is far from done. right? he has already brought one superseding indictment and the documents case. now we see that he...

BERLIN (Reuters) -Roche inadvertently published positive lung cancer drug trial data from an interim analysis, boosting the Swiss drug maker's shares even though more data will be needed to confirm the treatment's efficacy. Roche said on Wednesday that market participants had made it aware of the inadvertent disclosure of an interim data analysis on new immunotherapy tiragolumab, part of an experimental class of drugs known as anti-TIGIT. The read-out is not yet statistically signifi...

Push her to do something that he can raise money on down the road. but its shocking that he was told not to retaliate against a witness, and thats exactly what he has done on the pence tweet. he was told not to interfere, and thats exactly what the threats that he has made are doing. and when she says we expect a report by monday, and his lawyer say, im sorry, we dont think that makes sense. we want more time. then they have time to go on five television shows tomorrow morning, thats going to do...

His -- her calendar, and when that trial data is. and the one thing trump really wants is to delay the trial. and what hes going to find out is this trial is not going to be delayed. shes going to push it, and push it very hard but, to be done before the election. >> you bring up a really important point, well dig into it a little bit about the lawyers for trump here. but let me just ask really quickly, as cynthia to explain to us, myself and viewers, the difference between a protective order, w...

The expert panel switches its focus to endometrial cancer and discusses recent data from clinical trials.

Stephanie Graff, MD, and Rachel Layman, MD, discuss how they would apply the results of the monarchE trial to clinical case scenarios.

In the form and front of her mind. she told trumps team that she is basically going to set that aside. at one point, even expressed willingness to look at the march trial date in the hush money case, basically asking trumps team whether there was any flexibility on that schedule. though she didnt set a trial data today, it gives a little bit of a window into what she might be looking for on the calendar. >> bradley moss, we spent a lot of time the other night talking about jack smiths draft quar...